“…In the present study, in vivo microdialysis coupled with a validated UHPLC-MS/MS analytical method. 14 was used to investigate the transplacental transfer of remdesivir and its main metabolite, GS-441524, in the maternal blood, fetus, amniotic fluid, and placenta. The methodology used in this study was made compatible with the 3Rs principle (replacement, reduction, and refinement), by reducing the number of animals necessary for longitudinal sampling and measuring the pharmacologically relevant unbound form of the drug in the extracellular compartment.…”